Associations of Clinical Characteristics and Intestinal Flora Imbalance in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients and the Construction of an Early Warning Model

Int J Chron Obstruct Pulmon Dis. 2021 Dec 18:16:3417-3428. doi: 10.2147/COPD.S330976. eCollection 2021.

Abstract

Objective: Establish a simple predictive model and scoring rule that is suitable for clinical medical staff in respiratory departments to assess intestinal flora imbalance occurrence in stable chronic obstructive pulmonary disease (COPD) patients.

Methods: From January 1, 2019, to December 31, 2020, COPD patients (195 cases) - who attended the Outpatient Department, Respiratory and Critical Care, Yixing Hospital, Jiangsu University - were enrolled in a cross-sectional study. Based on stool examination results, patients were divided into experimental (41 cases) and control (154 cases) groups. Single-factor and logistic regression analyses were performed with the baseline data of the two groups to obtain a new predictive model, which was further simplified.

Results: Five predictive factors composed the model: body mass index (BMI), serum albumin (ALB), Charlson's Comorbidity Index (CCI), gastrointestinal symptom score (GSRs), and Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification. The model to predict intestinal flora imbalance in stable COPD patients had an area under the ROC curve (AUC) of 0.953 [95% CI (0.924, 0.982)]. After simplifying the scoring rules, the AUC was 0.767 [95% CI (0.676, 0.858)].

Conclusion: In the current study, we obtained a model that could effectively predict intestinal flora imbalance risk in stable COPD patients, being suitable for implementation in early treatments to improve the prognosis. Moreover, all indicators can be easily and simply obtained.

Keywords: chronic obstruction; early warning score; flora imbalance; gastrointestinal tract; lung disease; predictive model.

MeSH terms

  • Area Under Curve
  • Cross-Sectional Studies
  • Gastrointestinal Microbiome*
  • Humans
  • Prognosis
  • Pulmonary Disease, Chronic Obstructive*

Grants and funding

This work was supported in part by the National Natural Science Foundation of China (81802102), the Science Foundation of Jiangsu Health Commission (No. Z2018011) and the Top Talent Support Program for young and middle-aged people of Wuxi (Yixing) Health Committee (grant no. BJ2020107).